CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Public ClinicalTrials.gov record NCT06708299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CardiolRxTM in Recurrent Pericarditis (MAVERIC Phase 3) A Randomized, Double-blind, Placebo-controlled Trial
Study identification
- NCT ID
- NCT06708299
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cardiol Therapeutics Inc.
- Industry
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- CardiolRx Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2025
- Primary completion
- Sep 20, 2026
- Completion
- Oct 20, 2026
- Last update posted
- Mar 12, 2026
2025 – 2026
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clionic Arizona | Phoenix | Arizona | 85054 | Recruiting |
| UCI Health | Irvine | California | 92697 | Not yet recruiting |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | Recruiting |
| Mayo Clinic | Jacksonville | Florida | 32224 | Recruiting |
| Northwestern University | Chicago | Illinois | 60208 | Recruiting |
| Johns Hopkins University | Baltimore | Maryland | 21205 | Not yet recruiting |
| MedStar Health Institute | Columbia | Maryland | 21044 | Not yet recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Minneapolis Heart Institute | Minneapolis | Minnesota | 55407 | Not yet recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| NYU Langone Health | New York | New York | 10016 | Recruiting |
| Columbia University - New York Presbyterian | New York | New York | 10032 | Recruiting |
| Lenox Hill Hospital | New York | New York | 11030 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Recruiting |
| Houston Methodist Hospital | Houston | Texas | 77030 | Recruiting |
| University of Utah Hospital | Salt Lake City | Utah | 84112 | Not yet recruiting |
| University of Vermont | Burlington | Vermont | 05401 | Recruiting |
| University of Virginia | Charlottesville | Virginia | 22903 | Recruiting |
| Virginia Commonwealth University | Richmond | Virginia | 23219 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06708299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06708299 live on ClinicalTrials.gov.